
Thrombophilia
The new agent is on the 505(b)(2) regulatory pathway and was compared with tablet-form apixaban in 60 healthy volunteers.
A recent study in the Journal of the American Heart Association suggests that direct oral anticoagulants and ...
Advertisement
Expert Interviews on Hematology
Advertisement